Published online
doi:10.1084/jem.20071878
The Journal of Experimental Medicine, Vol. 205, No. 1, 207-218
The Rockefeller University Press, 0022-1007 $30.00
© Jain et al.
Innocuous IFN
induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production
Renu Jain1,
Danielle M. Tartar1,
Randal K. Gregg1,
Rohit D. Divekar1,
J. Jeremiah Bell1,
Hyun-Hee Lee1,
Ping Yu1,
Jason S. Ellis1,
Christine M. Hoeman1,
Craig L. Franklin2, and
Habib Zaghouani1,3
1 Department of Molecular Microbiology and Immunology, 2 Department of Veterinary Pathobiology, and 3 Department of Child Health, University of Missouri, Columbia, MO 65212
CORRESPONDENCE Habib Zaghouani: zaghouanih{at}health.missouri.edu
The role of Th17 cells in type I diabetes (TID) remains largely unknown. Glutamic acid decarboxylase (GAD) sequence 206–220 (designated GAD2) represents a late-stage epitope, but GAD2-specific T cell receptor transgenic T cells producing interferon
(IFN
) protect against passive TID. Because IFN
is known to inhibit Th17 cells, effective presentation of GAD2 peptide under noninflammatory conditions may protect against TID at advanced disease stages. To test this premise, GAD2 was genetically incorporated into an immunoglobulin (Ig) molecule to magnify tolerance, and the resulting Ig-GAD2 was tested against TID at different stages of the disease. The findings indicated that Ig-GAD2 could not prevent TID at the preinsulitis phase, but delayed TID at the insulitis stage. More importantly, Ig-GAD2 sustained both clearance of pancreatic cell infiltration and β-cell division and restored normoglycemia when given to hyperglycemic mice at the prediabetic stage. This was dependent on the induction of splenic IFN
that inhibited interleukin (IL)-17 production. In fact, neutralization of IFN
led to a significant increase in the frequency of Th17 cells, and the treatment became nonprotective. Thus, IFN
induced by an adjuvant free antigen, contrary to its usual inflammatory function, restores normoglycemia, most likely by localized bystander suppression of pathogenic IL-17–producing cells.
Abbreviations used: GAD, glutamic acid decarboxylase; HEL, hen egg lysozyme; IAA, insulin autoantibody; TID, type I diabetes.
R.K. Gregg's present address is Dept. of Basic Sciences, Philadelphia College of Osteopathic Medicine, Suwanne, GA 30024.
J. J. Bell's present address is Dept. of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
P. Yu's present address is National Cancer Institute Metabolism Branch, Bethesda, MD 20892.
H.-H. Lee's present address is Division of Immunology, Karp Laboratories, Children's Hospital, Harvard Medical School, Boston, MA 02115.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Mori, Y., Kodaka, T., Kato, T., Kanagawa, E. M., Kanagawa, O.
(2009). Critical role of IFN-{gamma} in CFA-mediated protection of NOD mice from diabetes development. Int Immunol
21: 1291-1299
[Abstract]
[Full Text]
-
Fallarino, F., Luca, G., Calvitti, M., Mancuso, F., Nastruzzi, C., Fioretti, M. C., Grohmann, U., Becchetti, E., Burgevin, A., Kratzer, R., van Endert, P., Boon, L., Puccetti, P., Calafiore, R.
(2009). Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. JEM
206: 2511-2526
[Abstract]
[Full Text]
-
Cui, G., Qin, X., Zhang, Y., Gong, Z., Ge, B., Zang, Y. Q.
(2009). Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice. J. Biol. Chem.
284: 28420-28429
[Abstract]
[Full Text]
-
Bradshaw, E. M., Raddassi, K., Elyaman, W., Orban, T., Gottlieb, P. A., Kent, S. C., Hafler, D. A.
(2009). Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells. J. Immunol.
183: 4432-4439
[Abstract]
[Full Text]
-
Li, L., Yi, Z., Wang, B., Tisch, R.
(2009). Suppression of Ongoing T Cell-Mediated Autoimmunity by Peptide-MHC Class II Dimer Vaccination. J. Immunol.
183: 4809-4816
[Abstract]
[Full Text]
-
Esensten, J. H., Lee, M. R., Glimcher, L. H., Bluestone, J. A.
(2009). T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function. J. Immunol.
183: 75-82
[Abstract]
[Full Text]
-
Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A., Shapiro, A.M. J.
(2009). Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice. Diabetes
58: 1302-1311
[Abstract]
[Full Text]
-
Ciric, B., El-behi, M., Cabrera, R., Zhang, G.-X., Rostami, A.
(2009). IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells. J. Immunol.
182: 5296-5305
[Abstract]
[Full Text]
-
Sutherland, A. P.R., Van Belle, T., Wurster, A. L., Suto, A., Michaud, M., Zhang, D., Grusby, M. J., von Herrath, M.
(2009). Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice. Diabetes
58: 1144-1155
[Abstract]
[Full Text]
-
Mangalam, A., Luckey, D., Basal, E., Jackson, M., Smart, M., Rodriguez, M., David, C.
(2009). HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice. J. Immunol.
182: 5131-5139
[Abstract]
[Full Text]
-
Perone, M. J., Bertera, S., Shufesky, W. J., Divito, S. J., Montecalvo, A., Mathers, A. R., Larregina, A. T., Pang, M., Seth, N., Wucherpfennig, K. W., Trucco, M., Baum, L. G., Morelli, A. E.
(2009). Suppression of Autoimmune Diabetes by Soluble Galectin-1. J. Immunol.
182: 2641-2653
[Abstract]
[Full Text]
-
Kim, H.-J., Jung, C.-G., Jensen, M. A., Dukala, D., Soliven, B.
(2008). Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy. J. Immunol.
181: 8753-8760
[Abstract]
[Full Text]
-
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., Kuchroo, V. K., Oukka, M.
(2008). IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA
105: 18460-18465
[Abstract]
[Full Text]
-
Pietropaolo, M., Surhigh, J. M., Nelson, P. W., Eisenbarth, G. S.
(2008). Primer: Immunity and Autoimmunity. Diabetes
57: 2872-2882
[Full Text]
-
Filippi, C. M., Juedes, A. E., Oldham, J. E., Ling, E., Togher, L., Peng, Y., Flavell, R. A., von Herrath, M. G.
(2008). Transforming Growth Factor-{beta} Suppresses the Activation of CD8+ T-Cells When Naive but Promotes Their Survival and Function Once Antigen Experienced: A Two-Faced Impact on Autoimmunity. Diabetes
57: 2684-2692
[Abstract]
[Full Text]
-
Spolski, R., Kashyap, M., Robinson, C., Yu, Z., Leonard, W. J.
(2008). IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA
105: 14028-14033
[Abstract]
[Full Text]
-
Mangalam, A., Luckey, D., Basal, E., Behrens, M., Rodriguez, M., David, C.
(2008). HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-{gamma}. J. Immunol.
180: 7747-7756
[Abstract]
[Full Text]